215 related articles for article (PubMed ID: 11307624)
1. Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study.
Klein R; Roggendorf W
Acta Neuropathol; 2001 Mar; 101(3):245-8. PubMed ID: 11307624
[TBL] [Abstract][Full Text] [Related]
2. Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade.
Zhu C; Kros JM; van der Weiden M; Zheng P; Cheng C; Mustafa DA
Acta Neuropathol Commun; 2017 Jan; 5(1):4. PubMed ID: 28073370
[TBL] [Abstract][Full Text] [Related]
3. Cellular proliferation in pilocytic and diffuse astrocytomas.
Giannini C; Scheithauer BW; Burger PC; Christensen MR; Wollan PC; Sebo TJ; Forsyth PA; Hayostek CJ
J Neuropathol Exp Neurol; 1999 Jan; 58(1):46-53. PubMed ID: 10068313
[TBL] [Abstract][Full Text] [Related]
4. Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology.
Yang I; Han SJ; Sughrue ME; Tihan T; Parsa AT
J Neurosurg; 2011 Sep; 115(3):505-11. PubMed ID: 21663411
[TBL] [Abstract][Full Text] [Related]
5. Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis.
Cummings TJ; Provenzale JM; Hunter SB; Friedman AH; Klintworth GK; Bigner SH; McLendon RE
Acta Neuropathol; 2000 May; 99(5):563-70. PubMed ID: 10805102
[TBL] [Abstract][Full Text] [Related]
6. MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults.
Matsumoto T; Fujii T; Yabe M; Oka K; Hoshi T; Sato K
Histopathology; 1998 Nov; 33(5):446-52. PubMed ID: 9839169
[TBL] [Abstract][Full Text] [Related]
7. Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors.
Nakamizo A; Inamura T; Ikezaki K; Yoshimoto K; Inoha S; Mizoguchi M; Amano T; Fukui M
J Neurooncol; 2002 Apr; 57(2):105-14. PubMed ID: 12125970
[TBL] [Abstract][Full Text] [Related]
8. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
[TBL] [Abstract][Full Text] [Related]
9. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
Heesters MA; Koudstaal J; Go KG; Molenaar WM
J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
[TBL] [Abstract][Full Text] [Related]
10. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
Geiger KD; Stoldt P; Schlote W; Derouiche A
Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of cyclin A in astrocytic tumours.
Chakrabarty A; Bridges LR
Neuropathol Appl Neurobiol; 1998 Jun; 24(3):239-45. PubMed ID: 9717190
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases.
Machen SK; Prayson RA
Hum Pathol; 1998 Dec; 29(12):1511-6. PubMed ID: 9865840
[TBL] [Abstract][Full Text] [Related]
13. WT1 Clone 6F-H2 Cytoplasmic Expression Differentiates Astrocytic Tumors from Astrogliosis and Associates with Tumor Grade, Histopathology, IDH1 Status, Apoptotic and Proliferative Indices: A Tissue Microarray Study.
Abd El-Hafez A; Ismail Hany HSED
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2403-2413. PubMed ID: 32856872
[TBL] [Abstract][Full Text] [Related]
14. The proliferative potential of the pilocytic astrocytoma: the relation between MIB-1 labeling and clinical and neuro-radiological follow-up.
Dirven CM; Koudstaal J; Mooij JJ; Molenaar WM
J Neurooncol; 1998 Mar; 37(1):9-16. PubMed ID: 9525833
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of peripheral benzodiazepine receptors in human astrocytomas and its correlation with grade of malignancy, proliferation, apoptosis and survival.
Vlodavsky E; Soustiel JF
J Neurooncol; 2007 Jan; 81(1):1-7. PubMed ID: 16868661
[TBL] [Abstract][Full Text] [Related]
17. Endothelial nitric oxide synthase expression in tumor vasculature is correlated with malignancy in human supratentorial astrocytic tumors.
Iwata S; Nakagawa K; Harada H; Oka Y; Kumon Y; Sakaki S
Neurosurgery; 1999 Jul; 45(1):24-8; discussion 29. PubMed ID: 10414562
[TBL] [Abstract][Full Text] [Related]
18. Gemistocytic astrocytomas: histomorphology, proliferative potential and genetic alterations--a study of 32 cases.
Avninder S; Sharma MC; Deb P; Mehta VS; Karak AK; Mahapatra AK; Sarkar C
J Neurooncol; 2006 Jun; 78(2):123-7. PubMed ID: 16614946
[TBL] [Abstract][Full Text] [Related]
19. Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis.
Kim CH; Bak KH; Kim YS; Kim JM; Ko Y; Oh SJ; Kim KM; Hong EK
Surg Neurol; 2000 Sep; 54(3):235-40. PubMed ID: 11118570
[TBL] [Abstract][Full Text] [Related]
20. Proliferating cell nuclear antigen (PCNA) and Ki-67 immunopositivity in human astrocytic tumours.
Kordek R; Biernat W; Alwasiak J; Liberski PP
Acta Neurochir (Wien); 1996; 138(5):509-12; discussion 513. PubMed ID: 8800324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
